Cargando…
基于二代测序技术分析骨髓纤维化患者基因突变对芦可替尼疗效的影响
OBJECTIVE: To assess the effect of gene mutations on the efficacy of ruxolitinib for treating myelofibrosis（MF）. METHODS: We retrospectively analyzed the clinical data of 56 patients with MF treated with ruxolitinib from July 2017 to December 2020 and applied second-generation sequencing（NGS）technol...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189480/ https://www.ncbi.nlm.nih.gov/pubmed/35680632 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.04.010 |